文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

马来西亚成年人血脂异常亚型及其相关个人和临床特征的高患病率:REDISCOVER 研究。

High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.

机构信息

Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Jalan Prima Selayang 7, 68100, Batu Caves, Selangor, Malaysia.

Department of Community Medicine, School of Medicine, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.

出版信息

BMC Cardiovasc Disord. 2021 Mar 23;21(1):149. doi: 10.1186/s12872-021-01956-0.


DOI:10.1186/s12872-021-01956-0
PMID:33757445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7988996/
Abstract

BACKGROUND: Dyslipidaemia refers to lipid abnormalities consisting of either one or any combination of the following: elevated total cholesterol (TC), elevated low-density lipoprotein cholesterol (LDL-c), elevated triglycerides (TG), and low high-density lipoprotein cholesterol (HDL-c). The prevalence of hypercholesterolaemia is steadily increasing in Malaysia. However, data on the prevalence of dyslipidaemia subtypes among Malaysians are lacking. This is important as it may have implications for preventive and management strategies for this increasing public health challenge. This study is aimed at determining the prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysians. METHODS: REDISCOVER, a prospective study, enrolled 11,288 adults where sociodemographic data, anthropometric and blood pressure measurements, fasting lipid profile and glucose, and history of diabetes, hypertension, and smoking were obtained. The cross-sectional analytic sample presented in this article comprised 10,482 participants from baseline recruitment. The data was analysed by descriptive statistics and multivariable logistic regression. RESULTS: The overall prevalence of elevated TC, elevated LDL-c, elevated TG, low HDL-c, and elevated non-HDL-c were 64.0% (95% CI 63.0-65.0), 56.7% (CI 55.7-57.7), 37.4% (CI 36.5-38.4), 36.2% (CI 35.2-37.1), and 56.2% (CI 55.3-57.2), respectively. Overweight, obesity, and central obesity were highly prevalent and significantly associated with elevated TC and all dyslipidaemia subtypes. Older age was associated with elevated TC, elevated LDL-c and elevated non-HDL-c. Hypertension was associated with elevated TC, elevated TG, and elevated non-HDL-c, while diabetes was associated with elevated TG and low HDL-c. CONCLUSIONS: Elevated TC and all dyslipidaemia subtypes are highly prevalent in Malaysia where increased body mass seems the main driver. Differences in the prevalence and associated personal and clinical attributes may facilitate specific preventive and management strategies.

摘要

背景:血脂异常是指一种或多种以下脂质异常:总胆固醇(TC)升高、低密度脂蛋白胆固醇(LDL-c)升高、甘油三酯(TG)升高和高密度脂蛋白胆固醇(HDL-c)降低。马来西亚的高胆固醇血症患病率稳步上升。然而,缺乏马来西亚人血脂异常亚型患病率的数据。这一点很重要,因为它可能对这一日益严重的公共卫生挑战的预防和管理策略产生影响。本研究旨在确定血脂异常亚型的患病率及其在马来西亚人中的相关个人和临床特征。

方法:RECOVER 是一项前瞻性研究,共纳入 11288 名成年人,获取社会人口统计学数据、人体测量学和血压测量、空腹血脂和血糖以及糖尿病、高血压和吸烟史。本文呈现的横断面分析样本由基线招募的 10482 名参与者组成。通过描述性统计和多变量逻辑回归分析数据。

结果:TC 升高、LDL-c 升高、TG 升高、HDL-c 降低和非 HDL-c 升高的总体患病率分别为 64.0%(95%CI 63.0-65.0)、56.7%(CI 55.7-57.7)、37.4%(CI 36.5-38.4)、36.2%(CI 35.2-37.1)和 56.2%(CI 55.3-57.2)。超重、肥胖和中心性肥胖非常普遍,与 TC 升高和所有血脂异常亚型显著相关。年龄较大与 TC、LDL-c 和非 HDL-c 升高相关。高血压与 TC、TG 和非 HDL-c 升高相关,而糖尿病与 TG 和 HDL-c 降低相关。

结论:TC 升高和所有血脂异常亚型在马来西亚都非常普遍,体重增加似乎是主要驱动因素。患病率和相关个人及临床特征的差异可能有助于制定特定的预防和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/35533c8adc8b/12872_2021_1956_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/a7c562e5d016/12872_2021_1956_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/35533c8adc8b/12872_2021_1956_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/a7c562e5d016/12872_2021_1956_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/35533c8adc8b/12872_2021_1956_Fig2_HTML.jpg

相似文献

[1]
High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.

BMC Cardiovasc Disord. 2021-3-23

[2]
Evaluation of Dyslipidaemia Using an Algorithm of Lipid Profile Measures among Newly Diagnosed Type II Diabetes Mellitus Patients: A Cross-Sectional Study at Dormaa Presbyterian Hospital, Ghana.

Medicina (Kaunas). 2019-7-21

[3]
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.

Endocrine. 2008

[4]
Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.

PLoS One. 2021-4-27

[5]
Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.

Sci Rep. 2022-1-10

[6]
A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia.

Sci Rep. 2023-7-7

[7]
[Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].

Wei Sheng Yan Jiu. 2014-9

[8]
High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi.

BMC Cardiovasc Disord. 2022-12-22

[9]
The burden of dyslipidaemia and factors associated with lipid levels among adults in rural northern Ghana: An AWI-Gen sub-study.

PLoS One. 2018-11-28

[10]
Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.

Cardiovasc J S Afr. 2005

引用本文的文献

[1]
Risk Factors for Post-Stroke Seizures in a Tertiary Care Center: A Case-Control Study.

Neuropsychiatr Dis Treat. 2024-8-26

[2]
Association between dyslipidaemia knowledge & lipid testing practice among adults, a community-based study.

PLoS One. 2024

[3]
Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review.

Diabetes Metab J. 2024-3

[4]
Age and Sex Differences in LDL Cholesterol Distribution in Adults in Malaysia: A Cross-Sectional Study (2010-2021).

Int J Gen Med. 2023-12-12

[5]
Prevalence of and factors associated with uncontrolled hypertension among patients with early chronic kidney disease attending tertiary hospitals in Dodoma, Tanzania: a cross-sectional study.

BMJ Open. 2023-12-12

[6]
Role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in Malaysia: A nationwide cross-sectional study.

PLoS One. 2023

[7]
Safety and efficacy of oil palm phenolic supplementation in improving lipid profile among hyperlipidemic adults: a phase 2, randomized, double-blind, placebo-controlled clinical trial.

Front Pharmacol. 2023-7-7

[8]
A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia.

Sci Rep. 2023-7-7

[9]
Hypercholesterolemia in the Malaysian Cohort Participants: Genetic and Non-Genetic Risk Factors.

Genes (Basel). 2023-3-15

[10]
Current Insights on Dyslipidaemia Management for Prevention of Atherosclerotic Cardiovascular Disease: A Malaysian Perspective.

Malays J Med Sci. 2023-2

本文引用的文献

[1]
The spectrum of the dyslipidemia in Colombia: The PURE study.

Int J Cardiol. 2018-11-5

[2]
Hypertriglyceridaemia and risk of coronary artery disease.

Nat Rev Cardiol. 2017-3-16

[3]
Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009.

J Lipids. 2014

[4]
Lipid profile parameters in Malaysian dyslipidemic patients.

Kobe J Med Sci. 2011-12-15

[5]
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.

Eur Heart J. 2011-4-29

[6]
High prevalence of low HDL-c in the Philippines compared to the US: population differences in associations with diet and BMI.

Asia Pac J Clin Nutr. 2010

[7]
Major lipids, apolipoproteins, and risk of vascular disease.

JAMA. 2009-11-11

[8]
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.

J Am Coll Cardiol. 2009-1-27

[9]
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.

Diab Vasc Dis Res. 2008-11

[10]
Lipid disorders among male factory shift workers in Kota Bharu, Kelantan.

Med J Malaysia. 2007-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索